Does cardiac troponin measurement predict adverse outcomes in patients with cardiovascular diseases other than acute coronary syndrome?
Elevated cardiac troponin in non-ACS patients indicates higher risk for adverse outcomes and should prompt investigation and management of underlying conditions.
Increased cardiac troponin indicates increased risk for adverse outcome in patients with various cardiovascular conditions beyond ACS. Routine measurement of cardiac troponin concentrations can however, not be generally recommended unless there is a suspicion of ACS. Nonetheless, any finding of an increased cardiac troponin concentration in a patient without ACS should at least prompt the search for possible underlying conditions and these should be managed meticulously according to current guidelines to improve outcome.
Eggers et al. (Tue,) studied this question.